Technetium-99m-ethyl cysteinate dimer brain perfusion loss in pediatric postictal psychosis.
Department of Nuclear Medicine, Sackler Faculty of Medicine, Tel Aviv University, Israel.
M
M
Lorberboym
A
A
Nissenkorn
E
E
Avrahami
T
T
Lerman-Sagie
D000927:Anticonvulsants / Q000627:therapeutic use; D001921:Brain / Q000000981:diagnostic imaging* / Q000473:pathology; D002648:Child; D003545:Cysteine / Q000031:analogs & derivatives; D003937:Diagnosis, Differential; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009460:Neurologic Examination; D015609:Organotechnetium Compounds; D011618:Psychotic Disorders / Q000000981:diagnostic imaging* / Q000209:etiology*; D019275:Radiopharmaceuticals; D013226:Status Epilepticus / Q000150:complications* / Q000188:drug therapy; D015899:Tomography, Emission-Computed, Single-Photon; D014057:Tomography, X-Ray Computed
D000927:Anticonvulsants; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C059659:technetium Tc 99m bicisate; D003545:Cysteine